Australia markets closed

Bioxyne Limited (BXN.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.02300.0000 (0.00%)
At close: 10:54AM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 17.31M
Enterprise value 13.51M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.47
Price/book (mrq)4.23
Enterprise value/revenue 5.96
Enterprise value/EBITDA -60.55

Trading information

Stock price history

Beta (5Y monthly) 0.49
52-week change 335.29%
S&P500 52-week change 3-13.21%
52-week high 30.0290
52-week low 30.0110
50-day moving average 30.0258
200-day moving average 30.0213

Share statistics

Avg vol (3-month) 3191.55k
Avg vol (10-day) 354.28k
Shares outstanding 5665.64M
Implied shares outstanding 6N/A
Float 8222.03M
% held by insiders 170.33%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 319 Mar 2012

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)31 Dec 2022


Profit margin -9.29%
Operating margin (ttm)-9.44%

Management effectiveness

Return on assets (ttm)-3.50%
Return on equity (ttm)-10.35%

Income statement

Revenue (ttm)2.35M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-9.90%
Gross profit (ttm)1.22M
EBITDA -213.88k
Net income avi to common (ttm)-217.85k
Diluted EPS (ttm)-0.0000
Quarterly earnings growth (yoy)409.00%

Balance sheet

Total cash (mrq)3.79M
Total cash per share (mrq)0.01
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)5.36
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-350.47k
Levered free cash flow (ttm)-296.97k